Avanos Medical, Inc.AVNSNYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+5.2%
5Y CAGR+5.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+5.2%/yr
vs -0.3%/yr prior
5Y CAGR
+5.1%/yr
Consistent
Acceleration
+5.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $410.60M | +20.3% |
| 2024 | $341.30M | +8.5% |
| 2023 | $314.70M | -10.7% |
| 2022 | $352.30M | +20.2% |
| 2021 | $293.10M | -8.3% |
| 2020 | $319.70M | -21.6% |
| 2019 | $407.60M | +14.5% |
| 2018 | $356.00M | +0.9% |
| 2017 | $352.90M | -3.7% |
| 2016 | $366.60M | - |